Introduction
Recent studies found the similar characters of tumorigenesis and gametogenesis, such as sustained mitosis of spermatogonia and infinite proliferation of cancer cell; haploidy in the meiosis of spermatocyte and aneuploidy in cancer cell; migration of primordial germ cell and metastasis of cancer cell (1) . Thus, it was proposed that genes involved in the gametogenesis can be re-activated and consequently drive the development of cancer independently in the absence of mutations in known oncogenes and tumor suppressor genes. Cancer-testis (CT) genes, which express only in germ cells and cancer cells, may be the basis of the above theory and participated in the process of carcinogenesis and cancer metastasis. Our previous work systematically identified CT genes in cancer patients and revealed that CT genes could be a new source of epi-driver candidates of cancers (2, 3) , which were also supported by the other recent studies (4) . Several CT genes, such as MAGEA3, FATE1, and LIN28B have been proved to contribute to the infinite proliferation of cancer cells (3) (4) (5) . Besides protein coding CT genes, our previous work found that a number of non-coding genes also presented the cancer-testis expression patterns and the function of CTlncRNA THOR and LIN28B-AS1 in cancers were also deciphered recently (2, 3, 6) . The results mentioned above suggested that protein-coding and non-coding CT genes could be the molecular basis of proliferation similarity between cancer cells and germ cells.
In addition to the similarity of proliferation ability, both germ cells and cancer cells showed ploidy alterations of the genome: the meiosis of spermatocytes generates haploid spermatids and cancer cells carried aneuploidy (7) . Aneuploidy is an unbalanced number of chromosomes and is a predominant cancer feature occurring in nearly 90% of solid tumors. The aneuploidy level in cancers is highly correlated with the reduced cytotoxic immune cells infiltration (8) . However, the origin and the role of aneuploidy in tumorigenesis is still unknown. There is emerging evidence that the inappropriate activation of meiotic chromosome regulator genes results in the chromosomal aberration and genome instability. HORMAD1, one of the earliest CT genes, are essential for the meiosis. The expression of HORMAD1 in breast cancer patients can promote nonhomologous end joining, an error-prone DNA repair pathway, and therefore driving genomic instability (9) . Recent TCGA study on aneuploidy also found the enrichment for the spermatogenesis pathway when investigating the aneuploidy-correlated genes (7) . However, there is no study systematically investigate the correlation between CT genes and aneuploidy.
In this study, we included transcriptomic and genomic data from 8,879 TCGA patients, 777 CCLE cell lines and single cell RNA-Seq data from testis to comprehensively illuminate a strong correlation between CT genes expressed in meiosis stage and aneuploidy events in cancers and create CTatals2 to query and visualize the correlation (http://45.62.103.54:41062/ctatlas2/). As well as protein-coding CT genes, non-coding CT genes were also associated with aneuploidy in cancers. With single-cell RNA-Seq data from cancer cells, we constructed a regulatory network to illuminate that the loss of "stabilizer" transcription factor RFX2/NFYA and the gain of "accelerator" transcription factor E2F7/E2F8 in cancers contribute to the correlation between CT genes and aneuploidy. Moreover, we presented data that the immunogenicity of classic CT antigens in cancer patients may be greatly weakened because of their correlation with aneuploidy.
Results
To systematically investigate whether CT genes were correlated with the aneuploidy level in cancer patients, we involved transcriptomic and genomic data from 21 cancer types, including bulk samples from 8,879 TCGA patients with solid tumors (Supplementary Table 1) . We involved 44,460 genes which expressed in at least 1% of all samples in the following analysis. To avoid the influence of the copy number of the genes and the purity of samples, we calculated the Spearman's partial correlation coefficients between aneuploidy score and the expression of each gene (TPM) after adjusting the gene's copy number and the purity. A ranked list of correlation coefficients was analyzed by gene set enrichment analysis (GSEA) with the predefined CT gene lists. We conducted the GSEA analysis on the protein-coding and non-coding genes, respectively.
A consistently positive correlation between meiosis-related CT protein-coding genes and aneuploidy score Firstly, we defined three types of CT protein-coding genes according to the evidence of testisspecific expression, as described in our previous work. A total of Interestingly, we observed a significant enrichment of high evidence CT genes in the GSEA analysis as well as moderate and low evidence CT genes (NEShigh = 1.76, P=1.45×10 -4 ; NESmoderate = 1.57, P=4.80×10 -4 ; NESlow = 1.61, P=3.10×10 -3 , Figure 1A ). Because spermatogenesis is a tightly regulated developmental process involved multiple stages, we included the single-cell RNA-seq data (10) ), while Spt-specific CT genes was not (NESSpt = 0.77, P=0.98)( Figure 1A ). The results in the moderate and low evidence CT genes were similar ( Figure   1A ). To further validate our classification, we involved an independent RNA-Seq data which include the transcriptomic profile of cells from three well-defined germ cell subtypes in testis and classify CT genes accordingly. Similarly, the enrichment of Spg-and Spc-specific and testis-universal CT genes were validated (Supplementary Figure 1) .
A previous TCGA study has revealed that proliferation pathways (such as E2F targets, mitotic spindle, and G2M checkpoint) were positively associated with aneuploidy scores. A number of CT genes were also included in the pathways mentioned above. Thus, we conducted GSEA analysis in each pathway to prove that the association between CT genes and aneuploidy scores was independent of the proliferation pathways. In E2F target gene set, for example, genes with cancertestis expression pattern showed significantly stronger correlation coefficients with aneuploidy level than the other non-CT E2F target genes (NES = 2.69, P = 1.01×10 -4 , Figure 2B ). Specially, Spcspecific CT genes had a largest normalized enrichment score (NES = 2.10, P = 1.10×10 -4 , Figure index in the calculation of the partial correlation coefficients between genes and aneuploidy score, the enrichment for CT genes vanished (NES = 1.19, P = 0.17, Figure 1D ). In contrary, if we adjusting the aneuploidy score in the calculation of the partial correlation coefficients between genes and HR deficiency index, the enrichment for CT genes are still significant (NES = 1.64, P < 1.00×10 -4 , Figure 1D ), indicating the correlations between CT genes and aneuploidy were dependent on HR deficiency. Thus, we mainly focused on the correlation between CT genes and HR deficiency in the following analysis. Then, we evaluated the correlation between gene expression and HR deficiency index in 777 CCLE cell lines of solid tumors and successfully validated the enrichment for specific
CT genes from meiosis stages (Supplementary Figure 2) .
We also performed the same analysis in each TCGA tumor type. We found the significant enrichment for CT genes in the majority of tumor types (15/ Figure 1E ). Generally, the enrichment scores were higher in early meiosis stages from differentiated spermatogonia to zygotene then in late meiosis stages from pachytene to diplotene ( Figure 1D ).
CT non-coding genes were also positively correlated with aneuploidy score in cancers
In our previous work, we noticed that non-coding genes with CT expression pattern also contribute to the development of cancers. Thus, we further explored the association between CT non-coding genes and aneuploidy level in cancers. Because we only obtained expression quantification of 1845
CT genes from single cell RNA-Seq data, we used the CT gene's classification based on RNA-Seq data from three germ cell subtypes (12) . GSEA analysis in TCGA cancer patients revealed the enrichment for high CT non-coding genes (NES = 1.27, P = 2.40×10 -4 , Figure 2A ) and the enrichment was immediately validated in the data from CCLE cell lines (NES = 1.36, P = 1.00× 10 -4 , Figure 2B ). The "off" of RFX2/NFYA and "on" of E2F7/E2F8/MYBL2 altered the regulatory networks of homologous recombination break and repair
Next, we studied why the reactivation of CT genes, which promises the well-organized meiosis in testis, were correlated with aneuploidy in cancers. Here, we first defined 81 CT protein-coding genes as HRD-CT genes, which had the top 1% partial correlation coefficients with HR deficiency index.
Then, we constructed a co-expression network by Weighted Correlation Network Analysis (WGCNA) in 259 GTEx testis tissues to explore the relationship between the HRD-related CT protein-coding genes. We identified 3 co-expression modules in normal testis tissues. Interestingly, we found that the majority of CT protein-coding genes (78.7%) and 80 of 81 HRD-related CT genes (98.8%) belonged to Module I (Supplementary Figure 4) . In addition, the connectivity level of HRD-CT genes was significantly higher than the other CT genes in Module I (Supplementary Figure   5) . Next, we constructed a co-expression network in each TCGA tumor type. Most HRD-CT genes (63.0%-100%) were still classified into a single module, however, a large number of Module I genes (27.3%-98.2%) lost its co-expression pattern with other Module I genes. In addition, the Module I genes was re-classified into multiple modules in tumors (Supplementary Figure 6) . The results suggested that the co-expression pattern between HRD-CT genes remained in tumors, but the pattern between HRD-CT genes and other Module I CT genes was lost.
The alterations of the co-expression pattern commonly indicated the change of upstream regulators. were activated in the stages of double-strand repair during late meiosis (16)( Figure 3A) . In HNSC and SKCM single-cell RNA-Seq data, we observed that Group I TFs were still activated in the tumor cells and regulated the HRD-CT genes, but Group II TFs were not activated in cancers( Figure   3B&C ). Instead, Group III (E2F7 and E2F8) consistently co-activated with Group I TFs in two types of cancer cells ( Figure 3B&C ).
Moreover, we observed a significantly negative enrichment for the CT genes activated only by Group II TFs in testis (NES=-1.94, P = 4.65×10 -4 , Figure 3D&E ) and a significantly positive enrichment for the CT genes activated only by Group III TFs in cancers (NES=2.18, P = 1.15×10 -3 , Figure 3D&E ). Given the above observations, we conclude that the sequential activation of Group I and Group II TFs during the meiosis may promise the balanced double-strand break and repair respectively, while the gain of Group III TFs strengthened double-strand break related with Group I TFs and the loss of Group II TFs weakened the repair process, which contributes to the homologous recombination deficiency and aneuploidy in cancers.
The correlation between CT genes and HRD diminished their correlation with infiltrating cytotoxic immune cells
Recent studies found that highly aneuploid tumors presented reduced expression of markers of cytotoxic infiltrating immune cells, especially CD8+ T cells. However, CT proteins were famous for their immunogenicity, which can induce the immune response. Thus, we further investigate whether the correlation between CT genes and immune infiltrating cells in cancers could be influenced by their association with HRD. In the analysis of the correlation between CT genes and infiltrating CD8+ T cells, we observe a significant enrichment for Spc-specific CT genes (NES=1.51, P = 2.14×10 -3 ). Interestingly, the enrichment score for Spg-and Spc-specific CT genes increased greatly after adjusting the HRD index in the calculation of partial correlation coefficients (NESSpg=1.94, P = 7.29×10 -4 ; NESSpc=1.99, P = 7.29×10 -4 , Figure 4A ). No enrichment was found for the Spt-specific and universally expressed CT genes. A similar increase was also seen in the analysis of correlation enrichment between Spg-specific CT genes and NK cells (NESmodel1=1.50, P = 4.70×10 -3 ; NESmodel2=2.50, P = 9.27×10 -3 , Figure 4A ). But for the other infiltrating lymphocytes, we did not found such an increase.
To further investigate which CT antigens' immunogenicity could be influenced by the HRD level, we compared the partial correlation coefficients between previously defined CT antigens and CD8+
infiltrating cells across the patients with lowest HRD score (0-2) and those with highest HRD score 
Discussion
The processes of germ cell development and tumor development share interestingly similarities.
CT genes, which are specifically expressed in testis and cancer tissues, were regarded as the molecular basis of the two processes. However, spermatogenesis is a tightly regulated developmental process and include multiple phases (10) . In each phase of human spermatogenesis, various developmental germ cell subtypes can be identified. Thus, systematic investigation of the CT genes expressed in specific germ cell subtypes will help the understanding of the similarity between germ cells and cancers. However, the dynamic transcriptome of the developmental process of sperm is difficult. Recently, the application of single-cell RNA-Seq on testicular cells greatly extended our knowledge on spermatogenesis and made it available to identify the spermatogenesis stage(s) similar to cancer development. In the present study, we integrated multiomics data from bulk samples and single cell RNA-Seq data to prove that CT genes involved in the meiosis stages were consistently correlated with aneuploidy in cancers. Although the aneuploidy-related CT genes were activated in the testis cells as well as in the cancer cells, our data showed their activation transcriptional factors were different. In addition, we found that the correlation between CT genes and aneuploidy can influence the immunogenicity of CT antigens.
Detailed information concerning the CT genes and their association with aneuploidy and tumor lymphocytes infiltration in this article is freely accessible through our search engine (CTatlas2:
http://45.62.103.54:41062/ctatlas2/).
However, meiosis is a unique and specialized cellular division process to create haploid gametes.
Homologous recombination is a hallmark of meiosis. In order to initiate homologous recombination and ensure proper homologous chromosome segregation, cells deliberately form numerous DNA double-strand breaks, though they are highly hazardous for genome integrity (17) Thus, meiotic DSB formation, processing, and repair are accurately regulated to promise their occurrence at the right time and place. Although the activation of CT genes can trigger the alteration of ploidy in the process of spermatogenesis as well as tumorigenesis, the process of aneuploidy generation accompanied chaotic breaks of DNA, which is quite distinct from the wellorganized haploid sperm cells generation. Our results revealed a group of "accelerator"
transcriptional factors, such as E2F7 and E2F8, can activate the genes associated with HRD as well as a series of genes involved in the cell cycle and proliferation. The overexpression E2F7
have been reported to result in an increase of aneuploidy in breast cancer cells (18) . On the contrary, another group of "stabilizer" transcriptional factors, such as RFX2 and NFYA, can activate a number of CT genes to promise the timely repair of double-strand breaks in the late meiosis stages, but these CT genes were not co-activated with HRD related CT genes in cancer cells. Thus, the gain of "accelerator" and the loss of "stabilizer" may contribute to the aberrant aneuploidy in cancers. These results also suggested that CT genes can serve as aneuploidy suppressors, though they were considered as oncogenes in cancers. CASC5 and SPATA18
represented these suppressors, as they were negatively correlated with the aneuploidy and HRD level and the knock out of the genes can result in the development of cancers (19) .
Another important point should be mentioned is that the association between CT genes and aneuploidy may influence the immunogenicity of CT genes. CT genes were first observed and considered to be candidate targets for immunotherapy due to their immunogenicity. However, The results suggested that the immunotherapy targeting on CT antigens should carefully evaluate their association with aneuploidy.
Methods

Public databases
We included genomic and transcriptomic data from bulk samples from 8,879 TCGA patients with solid tumors, and 777 cancer cell lines from CCLE databases. We also included single cell RNASeq data by Smart-Seq2 Technology from testis cells and two cancer types. The databases and related information were provided in Supplementary Table 1 . The abbreviation of cancer and sample sizes from the TCGA project were provided in Supplementary Table 2 .
RNA-Seq quantification
For RNA-Seq data from three germ cell subtypes from Jan et al.'s study, we applied standard expression quantification pipelines. Briefly, RNA reads were generated, aligned to the GENCODE v19 genome assembly with STAR v2.4.148, and quantified with RSEM (RSEM v1.2.12). TPM was used for the quantification of gene expression and following analysis.
Homologous recombination deficiency index
We calculated the homologous recombination deficiency index by an R package scarHRD, which determines the levels of homologous recombination deficiency (telomeric allelic imbalance, loss of heterozygosity, number of large-scale transitions) based on an array or sequencing data.
CT genes and the further classification of CT genes
We obtained CT genes information from our previous work (2) . CT genes were classified into the following five categories based on specificity measure (SPM) values:
(1) Spermatogonia (Spg) specific CT genes (SPMSpg>0.9 and expression in Spg > 0.1);
(2) Spermatocyte (Spc) specific CT genes (SPMSpc>0.9 and expression in Spc > 0.1); 
Gene set enrichment analysis (GSEA)
A gene set enrichment analysis (GSEA) was performed using partial Spearman's rank correlation coefficients between the all genes and aneuploidy level, HRD and infiltrating lymphocytes using the "fgsea" command from the Bioconductor package fgsea based on the CT genes classification mentioned above.
Construction of the regulatory network
The SCENIC analysis was run as described on the cells that passed the filtering, using the 20-thousand motifs database for RcisTarget and GRNboost (SCENIC version 0.1.5, which corresponds to RcisTarget 0.99.0 and AUCell 0.99.5; with RcisTarget.hg19.motifDatabases.20k).
The input matrix was the TPM for each dataset. Only shared genes across the databases were used for network construction. Only germ cells and tumor cells were used for analyses.
Statistic methods
All statistical tests were performed using a Wilcoxon rank-sum test for continuous data, Spearman's rank correlation or partial correlation for the estimation of correlation. Fisher's exact test was used to assess differences for the count data. Multiple testing corrections were performed where necessary using the Benjamini-Hochberg method. All reported P values are two-sided.
Figures were generated with the R packages ggplot2 (24) and RColorBrewer(25). A. Non-coding CT genes, especially Spg-and Spc-specific expressed CT genes were consistently associated with aneuploidy score in TCGA data;
B. Non-coding CT genes, especially Spg-and Spc-specific expressed CT genes were consistently associated with aneuploidy score in CCLE data;
C. Five non-coding CT genes were identified to be associated with aneuploidy in TCGA and CCLE databases. 
